Loading clinical trials...
Loading clinical trials...
Phase-I, Double-blind, Randomized, Placebo-controlled Single Center Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771 in Adult Healthy Human Volunteers
Conditions
Interventions
WCK 771 IV Infusion
Placebo IV Infusion
Locations
1
United States
PPD Phase I Clinic, 7551 Metro Center Drive, Suite 200
Austin, Texas, United States
Start Date
December 1, 2011
Primary Completion Date
February 7, 2012
Completion Date
June 27, 2012
Last Updated
December 7, 2022
NCT07063173
NCT07345130
NCT07046975
NCT06882681
NCT06641245
NCT06177483
Lead Sponsor
Wockhardt
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions